Medtronic plc
Dublin, Ireland · Biotechnology, Health Care, Manufacturing
Medtronic plc is the leading global healthcare technology company headquartered in Dublin, Ireland. The company's mission is to alleviate pain, restore health, and extend life by delivering innovative technologies that transform the lives of people around the world. With a global team of 95,000+ passionate people in over 150 countries, Medtronic's technologies and therapies treat 70 health conditi
Key facts
- Headquarters
- Dublin, Ireland
- Employees
- 56
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (MDT)
- Website
- Medtronic.com
- Company page
Recent activity at Medtronic plc
- : Michael Marinaro Appointed President of Medtronic
- : SEC 8-K (5.02):
- : Medtronic to exchange shares for MiniMed Group stock
- : Medtronic Appoints Lara Barghout as President of Interventional Cardiology Therapies
- : SEC 8-K (8.01): Medtronic plc entered into a material definitive agreement involving the issuance of multiple series of senior notes. The notes include various interest rates and maturity dates, with rates such as 1.125% due in 2027 and up to 4.200% due in 2045. The filing occurred on September 17, 2026, and details the terms of these financial instruments aimed at raising funds. This issuance is significant for the company as it can support capital needs, strategic initiatives, or refinance existing debt.
- : SEC 8-K (2.02): On September 1, 2026, Medtronic plc entered into multiple agreements regarding senior notes issuance, specifically detailing various maturities and interest rates. These include notes due between 2027 and 2053, with interest rates ranging from 0.375% to 4.200%. The strategic implication of issuing these notes allows Medtronic to raise capital potentially for expansion or debt refinancing, enhancing their liquidity position in the market. The transactions were formally reported in their SEC filing and are expected to impact the company's financial structure positively.
- : Medtronic Partners with Apollo Hospitals to Launch Advanced ICU in Hyderabad.
- : Medtronic to acquire SPR Therapeutics for chronic pain care
- : SEC 8-K (5.02): On May 18, 2026, Medtronic plc entered into a material definitive agreement for the issuance of various senior notes due between 2027 and 2053. This includes senior notes with different interest rates such as 1.125%, 0.375%, and 4.200%. The transaction involves significant debt instruments intended for potential refinancing and funding operations to better align with the company's long-term strategic goals. This issuance is critical for Medtronic's financial strategy and could impact its liquidity and capital structure going forward.
- : SEC 8-K (5.02): On May 18, 2026, Medtronic plc announced the departure of Brett Wall from his role as Executive Vice President and President of the Neuroscience Portfolio. Dr. Kweli Thompson, currently Senior Vice President and President of Cardiac Rhythm Management, will take over this position effective June 1, 2026. Brett Wall will remain with the company until September 1, 2026, to aid in the transition and will receive severance payments in line with the company's stated practices. This change is strategic as it reflects an internal move to align leadership in the Neuroscience sector amid company changes.
Leadership
- Luis Pereira, Country Director
- Michael Marinaro, Executive Vice President
- Lara Barghout, President
- Geoff Martha, Chief Executive Officer
- Thierry Piéton, Chief Financial Officer
Verified email and direct lines for Medtronic plc’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Medtronic plc files 13 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Medtronic plc in the news
- Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer - Medtronic (Oct 14, 2026)
- Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc. - Medtronic (Sep 14, 2026)
- Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance - Medtronic (Sep 01, 2026)
- Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years - Medtronic (Jun 03, 2026)
- Medtronic to announce financial results for its first quarter of fiscal year 2027 - Medtronic (Jul 20, 2026)
- Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain - Medtronic (Jul 16, 2026)
- Medtronic Announces Strategic Partnership with Cornerstone Robotics to Further Expand Global Access to Robotic-Assisted Surgery - Medtronic (Sep 01, 2026)
- A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - Medtronic (Jul 21, 2026)
Companies similar to Medtronic plc
- Conavi Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- medimaps group S.A · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- MedShift · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Encision · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Medu Group · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About Medtronic plc: questions and answers
What does Medtronic plc do?
Medtronic plc is the leading global healthcare technology company headquartered in Dublin, Ireland. The company's mission is to alleviate pain, restore health, and extend life by delivering innovative technologies that transform the lives of people around the world. With a global team of 95,000+ passionate people in over 150 countries, Medtronic's technologies and therapies treat 70 health conditi
Where is Medtronic plc headquartered?
Medtronic plc is headquartered in Dublin, Ireland.
How many employees does Medtronic plc have?
Medtronic plc has about 56 employees.
Who leads Medtronic plc?
Michael Marinaro is an Executive Vice President at Medtronic plc.
What is the latest news on Medtronic plc?
On Oct 19, 2026, Michael Marinaro Appointed President of Medtronic
Is Medtronic plc a public company?
Yes. Medtronic plc is publicly traded under the ticker MDT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy